You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

Terminated
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma
  • Saint Louis, Missouri
  • +1 more
Jan 18, 2023

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

Recruiting
  • Cytarabine+Thiotepa + Fludarabine + Busulfan
  • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • cytarabine+thiotepa+ fludarabine + busulfan
  • Hangzhou, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 26, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)

Not yet recruiting
  • Pediatric Acute Lymphoblastic Leukemia
  • +2 more
  • Sleep ALL Night
  • Boston, Massachusetts
  • +1 more
May 10, 2023

T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia/Lymphoma
  • Senl-T7
  • Beijing, Hebei, China
    Hebei yanda Hospital
Nov 22, 2022

PET-CT Imaging in Relapsed/Refractory Acute Leukemias

Not yet recruiting
  • B Cell
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 4, 2023

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    Infective Complications and Outcome of ALL Treated With INO

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
      • (no location specified)
      Aug 29, 2023

      Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

      Recruiting
      • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
      • Olverembatinib plus venetoclax and dexamethasone
      • Xi'an, Shannxi, China
        Department of Hematology, Xijing Hospital, Fourth Military Medic
      Oct 9, 2023

      Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)

      Completed
      Has Results
      • Acute Lymphoblastic Leukemia
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Dec 30, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Miltenyi CliniMACS Prodigy ® system
      • (no location specified)
      Mar 23, 2023

      Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • Low-field magnetic resonance imaging
      • +3 more
      • Erlangen, Bavaria, Germany
        Department of Pediatrics and Adolescent Medicine
      Oct 23, 2023

      Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • (no location specified)
      Oct 19, 2023

      T-cell Acute Lymphoblastic Leukemia Trial in Beijing (CD5 CAR-T)

      Recruiting
      • T-cell Acute Lymphoblastic Leukemia
      • CD5 CAR-T
      • Beijing, Beijing, China
        Xuanwu Hospital Capital Medical University
      Oct 23, 2022

      Clinical Significance of Occult Central Nervous System

      Recruiting
      • Acute Lymphoblastic Leukemia
      • cerebrospinal fluids exams
      • Roma, RM, Italy
        Tor Vergata University
      Mar 17, 2023

      Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

      Recruiting
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Acute Lymphoblastic Leukemia
      • VEN+AZA+Modified BUCY
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Apr 10, 2023

      MRD Detection by NGS in Pediatric B-ALL

      Completed
      • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
      • MRD
      • Hangzhou, Zhejiang, China
        The Children's Hospital of Zhejiang University School of Medicin
      Jul 25, 2023

      T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

      Recruiting
      • T-cell Acute Lymphoblastic Leukemia
      • +3 more
      • Universal CD7-specific CAR gene-engineered T cells
      • Beijing, Beijing, China
      • +2 more
      Aug 17, 2023

      Next-generation Sequencing in Pediatric B-ALL Children Patients

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, Pediatric
      • (no location specified)
      Apr 19, 2023

      Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

      Not yet recruiting
      • Lymphoblastic Leukemia
      • Palo Alto, California
        Stanford University
      Apr 27, 2023

      T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)

      Recruiting
      • T-lymphoblastic Lymphoma
      • +5 more
      • BCL2 Inhibitor plus IM2 regimen
      • Shanghai, Shanghai, China
        Shanghai General hospital,Shanghai Jiao Tong University School o
      Jan 10, 2023

      Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial (Brexucabtagene Autoleucel)

      Available
      • Mantle Cell Lymphoma
      • Acute Lymphoblastic Leukemia
      • Brexucabtagene Autoleucel
      • (no location specified)
      Mar 17, 2023

      B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • single dose of CNCT19
      • (no location specified)
      Dec 19, 2022

      Acute Lymphoblastic Leukemia Trial in Tianjin (CN201)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Oct 14, 2022